首页> 外文期刊>BMC Medical Genomics >Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data
【24h】

Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data

机译:使用离子洪流靶向深度测序数据的体制变体检测算法的比较

获取原文
           

摘要

The application of next-generation sequencing in cancer has revealed the genomic landscape of many tumour types and is nowadays routinely used in research and clinical settings. Multiple algorithms have been developed to detect somatic variation from sequencing data using either paired tumour-blood or tumour-only samples. Most of these methods have been developed and evaluated for the identification of somatic variation using Illumina sequencing datasets of moderate coverage. However, a comprehensive evaluation of somatic variant detection algorithms on Ion Torrent targeted deep sequencing data has not been performed. We have applied three somatic detection algorithms, Torrent Variant Caller, MuTect2 and VarScan2, on a large cohort of ovarian cancer patients comprising of 208 paired tumour-blood samples and 253 tumour-only samples sequenced deeply on Ion Torrent Proton platform across 330 amplicons. Subsequently, the concordance and performance of the three somatic variant callers were assessed. We have observed low concordance across the algorithms with only 0.5% of SNV and 0.02% of INDEL calls in common across all three methods. The intersection of all methods showed better performance when assessed using correlation with known mutational signatures, overlap with COSMIC variation and by examining the variant characteristics. The Torrent Variant Caller also performed well with the advantage of not eliminating a high number of variants that could lead to high type II error. Our results suggest that caution should be taken when applying state-of-the-art somatic variant algorithms to Ion Torrent targeted deep sequencing data. Better quality control procedures and strategies that combine results from multiple methods should ensure that higher accuracy is achieved. This is essential to ensure that results from bioinformatics pipelines using Ion Torrent deep sequencing can be robustly applied in cancer research and in the clinic.
机译:下一代测序在癌症中的应用揭示了许多肿瘤类型的基因组景观,现在是在研究和临床环境中常规使用的。已经开发了多种算法以检测使用配对肿瘤血液或仅肿瘤样品测序数据的体细胞变化。已经开发了这些方法中的大多数方法,用于使用中等覆盖的illumina测序数据集来识别体细胞变化。然而,尚未执行对离子血管靶向深度测序数据的综合评估离子Torrent目标深度测序数据。我们已经应用了三个体细胞检测算法,洪流变体呼叫者,蛋白质和varscan2,其大卵巢癌患者,其中包含208个成对的肿瘤血样和仅在330个扩增子上深入测序的253个肿瘤的样本。随后,评估了三个躯体变异呼叫者的一致性和性能。我们在整个三种方法中观察到算法中只有0.5%的算法,只有0.5%的SNV和0.02%的Indel呼叫。当使用与已知的突变签名的相关性评估时,所有方法的交叉点显示出更好的性能,与宇宙变异重叠并通过检查变体特性。 Torrent Variant来电者还具有很好的优势,而不是消除可能导致高类型II误差的大量变体。我们的结果表明,在将最先进的躯体变体算法应用于离子Torrent靶向深度测序数据时,应注意。更好的质量控制程序和结合多种方法结果的策略应确保实现更高的准确性。这对于确保使用离子洪流深度测序的生物信息学管道的结果是必不可少的,可以稳健地应用于癌症研究和诊所。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号